Accessibility Menu
Qian Yuan Baixing logo

Qian Yuan Baixing(OTC) QYBX

Market Cap$549.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-100%
5 Year-79%
1 Year-18%
1 Month-14%
$0.01
+0.00%
+0.00Today
Qian Yuan Baixing last closing stock price
MetricPriceDate
Last closeUSD 0.012026-08-24
Qian Yuan Baixing stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-35.48%USD 0.012026-08-05
1 month-14.16%USD 0.012026-07-06
3 month-28.49%USD 0.012026-05-22
Year to date+21.21%USD 0.002025-12-31
1 year-18.37%USD 0.012025-08-22
3 year+6.19%USD 0.012023-08-25
5 year-79.17%USD 0.032021-08-25
Since inception-99.56%USD 1.352008-04-08

Qian Yuan Baixing Financials at a Glance

Market Cap

$549.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.48M

Net Income (TTM)

$206.78K

EPS (TTM)

$0.00

P/E Ratio

3.16

Dividend

$0.00

Beta (Volatility)

-0.67 (Low)

Price

$0.01

Volume

10,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Aug 12, 2026

QYBX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Qian Yuan Baixing

Qian Yuan Baixing, Inc. is a technology company focused on acquiring and developing innovations in the medical equipment, diagnostic, and biotech sectors. Founded in 2005 and headquartered in Seattle, WA, the company aims to leverage advanced technologies to enhance healthcare solutions.

Products and Services
  • Medical equipment development and innovation
  • Diagnostic technology solutions
  • Biotech advancements for healthcare applications
Growth Outlook
  • Recent quarterly revenue of $506,387 shows potential for growth
  • Trailing twelve months (TTM) revenue of $2.5 million indicates upward trend
  • Operating income margin improved to 6.01% in the latest quarter
Financial Highlights
  • Net income of $27,128 reported for Q1 2026
  • Current ratio of 1.96 suggests strong liquidity position
  • Price-to-earnings (P/E) ratio of 7.15 indicates potential value
Qian Yuan Baixing, Inc. operates in a promising sector with a focus on medical technology, which is increasingly vital in today's healthcare landscape. The company's recent financial performance, including a notable increase in quarterly revenue and improved operating margins, reflects its potential for future growth. With a solid liquidity position and a favorable P/E ratio, Qian Yuan Baixing, Inc. presents an intriguing opportunity for investors interested in the technology and healthcare sectors. The company's commitment to innovation in medical equipment and diagnostics positions it well to capitalize on emerging trends in healthcare technology.
AI Generated • Aug 11, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

44

CEO

Zhi Cao

Website

www.mdcorp.com

Headquarters

Seattle, WA 98101, US

QYBX Financials

Key Financial Metrics (TTM)

Gross Margin

25.34%

Operating Margin

8.97%

Net Income Margin

8.34%

Return on Equity

14.35%

Return on Capital

7.49%

Return on Assets

7.15%

Earnings Yield

31.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$549.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

91.64M

Volume

10.00K

Avg. Volume

1.58K

Financials (TTM)

Gross Profit

$628.18K

Operating Income

$222.45K

EBITDA

$271.05K

Operating Cash Flow

$16.58K

Capital Expenditure

-$4.42K

Free Cash Flow

$12.16K

Cash & ST Invst.

$1.87M

Total Debt

$100.00K

Qian Yuan Baixing Performance Analysis

Qian Yuan Baixing annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 459,602154.2%
20232023-12-31USD 4,892,607964.5%
20242024-12-31USD 4,280,451-12.5%
20252025-12-31USD 2,308,562-46.1%
Qian Yuan Baixing sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-35.3%
Q42025-12-31217.5%
Q12026-03-31-37.0%
Q22026-06-3080.9%
Qian Yuan Baixing annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.00N/A
20232023-12-31USD 0.01N/A
20242024-12-31USD 0.00-70.5%
20252025-12-31USD 0.00-47.8%
Qian Yuan Baixing sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-133.3%
Q42025-12-31800.0%
Q12026-03-31-71.4%
Q22026-06-30400.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$915.82K

+134.1%

Gross Profit

$252.78K

+120.6%

Gross Margin

27.60%

N/A

Market Cap

$549.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$36.66K

N/A

Employees

15

N/A

Net Income

$120.24K

+230.3%

EBITDA

$147.58K

+320.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.87M

+18.1%

Total Debt

$100.00K

+0.0%

Accounts Receivable

$307.94K

-24.8%

Inventory

$302.52K

+42.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$100.00K

+0.0%

Return on Assets

7.15%

N/A

Return on Invested Capital

13.91%

N/A

Free Cash Flow

$247.78K

-34.5%

Operating Cash Flow

$247.78K

-34.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICTYEyeCity.com, Inc.
$0.00+0.00%
IVFZFMapath Capital Corp
$0.01+0.00%
CCAJCoastal Capital Acquisition Corp.
$0.00-36.36%
MNDPMundus Group, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$229.37+0.09%
INTCIntel
$90.79+0.03%
BITOProShares Trust - ProShares Bitcoin ETF
$10.85+0.03%
NOKNokia
$10.63+0.02%

Questions About QYBX

What is the current price of Qian Yuan Baixing?

Qian Yuan Baixing is trading at $0.01 per share.

What is the 52-week range for Qian Yuan Baixing?

Over the past 52 weeks, Qian Yuan Baixing has traded between $0.00 and $0.01.

How much debt does Qian Yuan Baixing have?

As of the most recent reporting period, Qian Yuan Baixing reported total debt of $100.00K.

How much cash does Qian Yuan Baixing have on hand?

Qian Yuan Baixing reported $1.87M in cash and cash equivalents in its most recent financial results.

What is Qian Yuan Baixing’s dividend yield?

Qian Yuan Baixing does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services